Spironolactone Suspension
Product Images NDC 0574-1133

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 0574-1133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure diagram of spironolactone, the active ingredient in SPIRONOLACTONE oral suspension. The illustration shows the molecular framework with labeled chemical groups, including a lactone ring and a thioacetate moiety.*

FDA Label Image

Figure 1. Survival By Treatment Group In Rales (Figure 01)

A Kaplan-Meier survival curve comparing the probability over time in months between two groups: one treated with spironolactone (n=822) and a placebo group (n=841). The graph shows higher survival probability for the spironolactone group with a statistically significant log-rank p-value of less than 0.001.*

FDA Label Image

Label Image (Label)

Label for Spironolactone Oral Suspension 25 mg/5 mL by Padagis US LLC. The label indicates the product is Rx only, for oral use, and should be shaken well before use. The container size is 118 mL. Storage instructions note controlled room temperature (20°-25°C). Barcode and distributor address in Allegan, MI, are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.